Details of the Drug

General Information of Drug (ID: DMVQQY4)

• Drug Name: T-1210

Indication

Disease Entry	ICD 11	Status	REF
Allergic conjunctivitis	9A60.02	Phase 2	[1]

• Cross-matching ID: TTD ID: D06QQH

References

• [1] ClinicalTrials.gov (NCT01344083) Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis. U.S. National Institutesof Health.